This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 9, 2021
Delivered DigitallyUS Eastern Daylight Time

Mirodia Therapeutics


Mirodia Therapeutics is a NewCo whose mission is to develop topical disease-modifying regenerative medicines for olfactory loss / dysfunction (anosmia / hyposmia). Anosmia / hyposmia are associated with increased morbidity & mortality & represent a potentially new and significant category for which there are no approved disease-modifying therapeutics. Mirodia Therapeutics provides a unique opportunity to establish a leadership position in addressing this significant unmet clinical need.